This agreement gives the company the exclusive distribution rights to Co-Diagnostics' qPCR infectious disease kits, Logix Smart COVID-19 PCR diagnostic test and Co-Dx Box instrument, in Afghanistan, Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan and Uzbekistan.
This agreement follows the execution of agreements with Co-Diagnostics for Russia, Ecuador, Panama, Romania and Moldova. PreCheck's eleven combined distribution territories have an aggregate population of 298m.
PreCheck believes Co-Diagnostics' Coronavirus COVID-19 PCR test is the most accurate test to detect the presence of the COVID-19 infection. Co-Diagnostics has announced that it was the first US company to obtain a CE marking for a COVID-19 test.
CE marking is a certification mark that indicates conformity with health, safety, and environmental protection standards for products sold within the European Economic Area.
The CE marking is also found on products sold outside the EEA that have been manufactured to EEA standards.
PreCheck Health Services, Inc. is a distributor of the PC8B, a medical screening device, for use by physicians in managing a patient's health which it purchases from a domestic supplier, and, since March 2020, a distributor of Co-Diagnostics' tests, including its tests for the COVID-19.
Halma acquires Rovers Medical Devices
boston Scientific granted FDA approval for AGENT Drug-Coated Balloon
Enable Injections names new chief operating officer
BridgeBio Pharma and Kyowa Kirin partner on infigratinib for skeletal dysplasias in Japan
Redwood Scientific signs agreement with Jeeva Clinical Trials
Tissue Regenix ships first allograft products in the EU post-HPRA approval
Kromek secures GBP1.3m grant for AI-powered radiation sensor project